A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
Cadre Holdings, Inc. operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, Healthcare sector. Full business description from SEC filing not yet available.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 619M | 568M | 483M | 458M | 427M | 405M |
| Net Income | 45M | 36M | 39M | 5.8M | 13M | 38M |
| EPS | $1.11 | $0.90 | $1.02 | $0.16 | $0.44 | $1.40 |
| Free Cash Flow | 61M | 26M | 66M | 42M | 37M | 41M |
| ROIC | 7.9% | 10.2% | 12.2% | 3.3% | 13.7% | 31.0% |
| Gross Margin | 42.7% | 41.1% | 41.6% | 38.4% | 39.9% | 37.8% |
| Debt/Equity | 0.91 | 0.72 | 0.71 | 0.90 | 1.80 | 24.04 |
| Dividends/Share | $0.37 | $0.35 | $0.32 | $0.32 | $0.44 | - |
| Operating Income | 76M | 67M | 57M | 17M | 52M | 50M |
| Operating Margin | 12.3% | 11.8% | 11.7% | 3.7% | 12.1% | 12.3% |
| ROE | 13.3% | 14.2% | 19.6% | 3.5% | 14.3% | 434.4% |
| Shares Outstanding | 41M | 40M | 38M | 36M | 29M | 27M |
| Metric | 2020 | 2021 | 2022 | |||
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 405M | 427M | 458M | 483M | 568M | 619M |
| Gross Margin | 37.8% | 39.9% | 38.4% | 41.6% | 41.1% | 42.7% |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT | 50M | 52M | 17M | 57M | 67M | 76M |
| Op. Margin | 12.3% | 12.1% | 3.7% | 11.7% | 11.8% | 12.3% |
| Net Income | 38M | 13M | 5.8M | 39M | 36M | 45M |
| Net Margin | 9.5% | 3.0% | 1.3% | 8.0% | 6.4% | 7.3% |
| Non-Recurring | 5.8M | 3.4M | 4.4M | 2.2M | 6.0M | 6.0M |
| Returns on Capital | ||||||
| ROIC | 31.0% | 13.7% | 3.3% | 12.2% | 10.2% | 7.9% |
| ROE | 434.4% | 14.3% | 3.5% | 19.6% | 14.2% | 13.3% |
| ROA | 13.6% | 4.1% | 1.5% | 9.0% | 6.7% | 5.7% |
| Cash Flow | ||||||
| Op. Cash Flow | 45M | 40M | 46M | 73M | 32M | 66M |
| Free Cash Flow | 41M | 37M | 42M | 66M | 26M | 61M |
| Owner Earnings | 31M | 26M | -1.1M | 48M | 7.0M | 41M |
| CapEx | 4.7M | 2.8M | 4.5M | 6.7M | 5.7M | 4.9M |
| Maint. CapEx | 15M | 14M | 16M | 16M | 16M | 16M |
| Growth CapEx | 0 | 0 | 0 | 0 | 0 | 0 |
| D&A | 15M | 14M | 16M | 16M | 16M | 16M |
| CapEx/OCF | N/A | 7.1% | 9.7% | 9.2% | 17.8% | 7.4% |
| Capital Allocation | ||||||
| Dividends Paid | 0 | 13M | 12M | 12M | 14M | 15M |
| Dividend Yield | N/A | 2.3% | 1.4% | 1.3% | 1.0% | 1.1% |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Stock-Based Comp | N/A | 355K | 32M | 9.4M | 8.4M | 8.4M |
| Debt Repayment | 276M | 266M | 10M | 10M | 43M | 43M |
| Balance Sheet | ||||||
| Net Debt | 213M | 160M | 150M | 140M | 223M | 311M |
| Cash & Equiv. | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | 209M | 147M | 137M | 128M | 212M | 212M |
| Debt/Equity | 24.04 | 1.80 | 0.90 | 0.71 | 0.72 | 0.91 |
| Interest Coverage | 2.0 | 3.1 | 2.7 | 12.5 | 8.5 | 8.5 |
| Equity | 8.9M | 89M | 166M | 197M | 312M | 340M |
| Total Assets | 283M | 312M | 392M | 431M | 653M | 792M |
| Total Liabilities | 274M | 223M | 226M | 234M | 341M | 452M |
| Intangibles | 117M | 109M | 132M | 125M | 256M | 256M |
| Retained Earnings | -37M | -37M | -43M | -16M | 6.1M | 6.1M |
| Working Capital | 55M | 85M | 118M | 151M | 233M | 233M |
| Current Assets | 117M | 160M | 197M | 246M | 328M | 328M |
| Current Liabilities | 62M | 75M | 79M | 95M | 94M | 94M |
| Per Share Data | ||||||
| EPS | 1.40 | 0.44 | 0.16 | 1.02 | 0.90 | 1.11 |
| Owner EPS | 1.12 | 0.90 | -0.03 | 1.27 | 0.17 | 1.02 |
| Book Value | 0.32 | 3.08 | 4.56 | 5.20 | 7.76 | 8.37 |
| Cash Flow/Share | 1.65 | 1.39 | 1.28 | 1.93 | 0.79 | 1.52 |
| Dividends/Share | N/A | 0.44 | 0.32 | 0.32 | 0.35 | 0.37 |
| Shares Out. | 27.5M | 28.8M | 36.4M | 37.9M | 40.1M | 40.7M |
| Valuation | ||||||
| P/E Ratio | N/A | 51.0 | 117.7 | 31.7 | 35.1 | 29.9 |
| P/FCF | N/A | 17.3 | 16.3 | 18.4 | 48.6 | 22.0 |
| EV/EBIT | N/A | 15.6 | 49.9 | 24.1 | 22.4 | 21.8 |
| Price/Book | N/A | 7.3 | 4.1 | 6.2 | 4.1 | 4.0 |
| Price/Sales | N/A | 1.3 | 1.8 | 1.9 | 2.4 | 2.2 |
| FCF Yield | N/A | 5.8% | 6.1% | 5.4% | 2.1% | 4.5% |
| Market Cap | N/A | 645M | 685M | 1.2B | 1.3B | 1.4B |
| Avg. Price | N/A | 18.98 | 23.14 | 23.63 | 34.15 | 33.23 |
| Year-End Price | N/A | 22.43 | 18.83 | 32.30 | 31.63 | 33.23 |
Cadre Holdings, Inc. passes 4 of 9 quality checks, suggesting mixed fundamentals.
Cadre Holdings, Inc. trades at 29.9x trailing earnings, compared to its 15-year median P/E of 35.1x, suggesting it is currently Fair relative to its historical range. On a free-cash-flow basis, the stock trades at 22.0x vs a median of 17.9x. The company's 5-year average ROIC is 14.1% with a gross margin of 39.8%. Total shareholder yield (dividends) is 1.1%. At current prices, the estimated annualized return to fair value is -4.4%.
Cadre Holdings, Inc. (CDRE) has a current P/E ratio of 29.9, compared to its historical median P/E of 35.1. The stock is currently considered Fair based on its historical valuation range.
Cadre Holdings, Inc. (CDRE) has a 5-year average return on invested capital (ROIC) of 14.1%. This indicates solid capital allocation.
Cadre Holdings, Inc. (CDRE) has a market capitalization of $1.4B. It is classified as a small-cap stock.
Yes, Cadre Holdings, Inc. (CDRE) pays a dividend with a trailing twelve-month yield of 1.12%.
Based on historical P/E analysis, Cadre Holdings, Inc. (CDRE) appears fair. The current P/E of 29.9 is 15% below its historical median of 35.1. The estimated fair value CAGR (P/E method) is 25.3%.
Cadre Holdings, Inc. (CDRE) operates in the Orthopedic, Prosthetic & Surgical Appliances & Supplies industry, within the Healthcare sector.
Cadre Holdings, Inc. (CDRE) reported annual revenue of $568 million in its most recent fiscal year, based on SEC EDGAR filings.
Cadre Holdings, Inc. (CDRE) has a net profit margin of 6.4%. This is a modest margin.
Cadre Holdings, Inc. (CDRE) generated $26 million in free cash flow in its most recent fiscal year. Positive free cash flow supports dividends, buybacks, and debt reduction.
Cadre Holdings, Inc. (CDRE) has a debt-to-equity ratio of 0.72. This indicates moderate leverage.
Cadre Holdings, Inc. (CDRE) reported earnings per share (EPS) of $0.90 in its most recent fiscal year.
Cadre Holdings, Inc. (CDRE) has a return on equity (ROE) of 14.2%. This indicates moderate shareholder returns.
Cadre Holdings, Inc. (CDRE) has a 5-year average gross margin of 39.8%. This indicates decent pricing power.
The Ledger Terminal provides 5 years of financial data for Cadre Holdings, Inc. (CDRE), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Cadre Holdings, Inc. (CDRE) has a book value per share of $7.76, based on its most recent annual SEC filing.